GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
M

Medipal Holdings 7459.T · JPY

Health Care · Tokyo Stock Exchange · 🇯🇵 Japan

Compare

3,196

+0.06%

Close of 9 Nov 2026, in JPY

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in JPY, from our data supplier.

FY2026

Revenue

¥3.82trn

FY2017FY2026

Net income

¥42.53bn

FY2017FY2026

Free cash flow

¥39.93bn

FY2017FY2026

Shareholders' equity

¥652.17bn

FY2017FY2026

Income statement

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Revenue¥3.82trn¥3.67trn¥3.56trn¥3.36trn¥3.29trn¥3.21trn¥3.25trn¥3.18trn¥3.15trn¥3.06trn
Gross profit¥247.41bn¥242.25bn¥233.01bn¥212.12bn¥205.11bn¥201.49bn¥224.25bn¥220.62bn¥214.84bn¥207.11bn
Research and development—¥1.42bn¥991.0m¥103.0m¥108.0m¥106.0m¥118.0m———
Operating income¥53.18bn¥55.61bn¥47.33bn¥48.97bn¥45.63bn¥38.58bn¥53.11bn¥49.47bn¥44.26bn¥39.26bn
Net income¥42.53bn¥40.28bn¥41.48bn¥38.81bn¥29.42bn¥23.93bn¥37.97bn¥34.36bn¥34.78bn¥29.01bn
Diluted earnings per share207.79196.29199.45183.75138.26107.24173.20152.54147.55123.58

Balance sheet

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Total assets¥1.92trn¥1.82trn¥1.80trn¥1.70trn¥1.71trn¥1.68trn¥1.64trn¥1.62trn¥1.62trn¥1.53trn
Cash and short-term investments¥289.07bn¥261.41bn¥230.47bn¥195.03bn¥261.92bn¥241.52bn¥226.31bn¥231.79bn¥222.32bn¥184.04bn
Total liabilities¥1.13trn¥1.07trn¥1.06trn¥1.02trn¥1.06trn¥1.04trn¥1.04trn¥1.03trn¥1.05trn¥1.00trn
Debt—¥4.17bn¥1.46bn¥7.38bn¥36.48bn¥38.07bn¥44.85bn¥54.63bn¥67.66bn¥41.67bn
Shareholders' equity¥652.17bn¥619.57bn¥600.35bn¥561.36bn¥530.30bn¥523.01bn¥500.32bn¥496.88bn¥484.67bn¥441.61bn
Shares outstanding205m205m208m211m213m223m219m225m236m235m

Cash flow

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash from operations¥46.55bn¥60.56bn¥61.84bn¥16.15bn¥61.22bn¥34.45bn¥56.92bn¥63.72bn¥63.56bn¥47.95bn
Capital spending−¥6.62bn−¥8.86bn−¥15.56bn−¥13.50bn−¥18.88bn−¥15.67bn−¥27.35bn−¥14.58bn−¥25.60bn−¥32.33bn
Free cash flow¥39.93bn¥51.70bn¥46.28bn¥2.64bn¥42.34bn¥18.78bn¥29.57bn¥49.14bn¥37.96bn¥15.62bn
Dividends paid−¥13.22bn−¥12.54bn−¥11.18bn−¥9.66bn−¥8.82bn−¥8.82bn−¥8.65bn−¥8.05bn−¥7.22bn−¥6.79bn

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Revenue¥989.50bn¥905.69bn¥1.01trn¥952.40bn¥945.16bn¥864.16bn¥982.50bn¥915.36bn
Gross profit¥62.22bn¥58.52bn¥65.34bn¥62.23bn¥61.33bn¥58.13bn¥64.41bn¥60.46bn
Operating income¥13.39bn¥10.00bn¥18.10bn¥11.03bn¥14.05bn¥10.24bn¥18.21bn¥13.88bn
Net income¥13.65bn¥5.12bn¥15.32bn¥12.50bn¥9.59bn¥4.04bn¥14.51bn¥12.72bn
Diluted earnings per share66.6625.0174.6860.9346.7219.7069.7861.16
Total assets¥1.94trn¥1.92trn¥2.02trn¥1.91trn¥1.85trn¥1.82trn¥1.96trn¥1.88trn
Cash and short-term investments¥289.92bn¥289.07bn¥275.87bn¥276.63bn¥246.03bn¥261.41bn¥249.46bn¥251.38bn
Debt—————¥932.0m——
Shareholders' equity¥649.73bn¥652.17bn¥641.21bn¥623.68bn¥616.58bn¥619.57bn¥626.00bn¥618.44bn

Growth per year

Compound annual rate

3 years5 years10 years
Revenue4.3%3.5%2.3%
Operating income2.8%6.6%2.4%
Net income3.1%12.2%3.3%

Average margins

Over each period

1 year3 years5 years10 years
Gross margin6.5%6.5%6.4%6.6%
Operating margin1.5%1.4%1.4%1.4%
Net margin1.1%1.1%1.0%1.0%

Valuation history

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Price to earnings17.014.111.912.412.620.111.215.816.017.9
Price to sales0.20.10.10.10.10.10.10.20.20.2

Dividends and splits

Per share, in the currency the company pays

Paid for 34 years. Last went ex-dividend on 29 Sept 2026.

FY2027FY2026FY2025FY2024FY2023FY2022FY2021FY2020
Paid in the year44.0096.0060.0053.0046.0042.0042.0040.00
  • 1.1-for-1 split · 26 Mar 1996

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.